January 16, 2026: As Zepbound Drives Eli Lillys Revenue, More People File Lawsuits Claiming Injuries from the Drug In the federal MDL, there are 3,063 pending lawsuits against Eli Lilly and other GLP-1 drug makers (as of January 5, 2026)
Cognitive impairment phenotypes in patients with CKD stages 3b and 4
10 mg/0.5mL
When used as part of a comprehensive plan of care and healthy nutrition, BPC-157 can seemingly work wonders
KPV addresses the inflammatory cascade at the cellular signaling level: it inhibits NF-kB nuclear translocation, suppresses the transcriptional output of inflammatory genes, and via PepT1 delivers this inhibition specifically to the inflamed intestinal cells that are perpetuating the damage
The more times you access the vial, the higher the statistical probability of introducing a contaminant becomes